Back
AptarGroup, Inc. (ATR)
PackagingATR · NEW YORK STOCK EXCHANGE, INC. · USD
New to investing? How to read this page →$124.45
+0.19%Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for education and research only — not financial advice.
Key metrics
EPS
$5.89
ROE
14.8%
Gross margin
36.7%
Debt/Equity
0.54x
Revenue growth
10.8%
AptarGroup, Inc. — company intelligence
Earnings surprises
Q1 2026$1.19 vs $1.16 est+2.3%
Q4 2025$1.25 vs $1.24 est+0.7%
Q3 2025$1.62 vs $1.58 est+2.4%
Q2 2025$1.66 vs $1.58 est+5.1%
Insider activity · 90 days
18 buys14 sellsnet +50,424 shares
Gandhi AdityaBuy 2,664 · Jun 15, 2026
Prieur MarcSell 447 · Jun 9, 2026
Prieur MarcSell 4,553 · Jun 9, 2026
Recent SEC filings
4 — Insider transaction reportJun 16, 2026
4 — Insider transaction reportJun 10, 2026
4 — Insider transaction reportJun 5, 2026
Latest news
AptarGroup Has Fallen Enough (Rating Upgrade) — SeekingAlpha · 1w ago
Aptar Releases 2025 Corporate Sustainability Report — Yahoo · 3w ago
Is West Pharmaceutical Stock Outperforming the S&P 500? — Yahoo · 3w ago
AptarGroup, Inc. (ATR) Presents at Jefferies Global Healthcare Conference 2026 - Slideshow — SeekingAlpha · Jun 10, 2026
AptarGroup, Inc. (ATR) Presents at 16th Annual Wells Fargo Industrials & Materials Conference Transcript — SeekingAlpha · Jun 10, 2026
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
About AptarGroup, Inc.
Weekly undervalued picks (like ATR)
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.